WHO ICTRP trial

A Comparison of Ropivacaine with Tramadol vs. Ropivacaine with Nalbuphine for…

CTRI/2025/02/081012 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2025/02/081012
Public title A Comparison of Ropivacaine with Tramadol vs. Ropivacaine with Nalbuphine for Pain Management in Lower Abdominal Surgeries
Scientific title An Observational study of comparison of Isobaric Ropivacaine 0.75% with Tramadol and Isobaric Ropivacaine 0.75% with Nalbuphine intrathecally in infra-umbilical surgeries - NIL
Primary sponsor Smt Bhikiben Kanjibhai Shah Medical Institute and Research Center
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: O- Medical and Surgical
Interventions Control Intervention1: Patients receiving Isobaric Inj.Ropivacaine 0.75% 3.5 ml with 1mg Inj.Nalbuphine(0.1ml) diluted till 0.5 ml with sterile NS.: level of sensory block will be assessed at 2 and 5 min post injection and 5-min intervals…
Registration date Feb 20, 2025
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations